| SGN‐2FF | |
| Generic Name | SGN‐2FF |
| Company Name | Seagen Inc. |
| Drug Type | Small molecule |
| Drug Class | fucosylation inhibitor |
| Dose | 2 and 5 g QD grams (g) per flat dose |
| Route | oral (po) |
| Pembrolizumab | |
| Generic Name | Pembrolizumab |
| Trade Name | Keytruda |
| Company Name | Merck |
| Drug Type | Antibody |
| Drug Class | Immune therapy |
| Dose | 200 mg per flat dose |
| Route | IV |